(redirected from low-density lipoprotein cholesterol)
Also found in: Dictionary, Thesaurus, Medical, Encyclopedia.
Related to low-density lipoprotein cholesterol: LDL-C
cLDLLow-Density Lipoprotein Cholesterol (more commonly seen as LDL)
Copyright 1988-2018, All rights reserved.
References in periodicals archive ?
Accuracy of calculated serum low-density lipoprotein cholesterol for the assessment of coronary heart disease risk in NIDDM patients.
Comparison of a novel method vs the Friedewald equation for estimating low-density lipoprotein cholesterol levels from the standard lipid profile.
measured weight, height, body composition, blood pressure, heart rate, glucose, insulin, total cholesterol, low-density lipoprotein cholesterol and high-density lipoprotein cholesterol, triglycerides, and high sensitivity C-reactive protein (hs-CRP) levels, Before Ramzan, during the last week of Ramzan.
Why is non-high-density lipoprotein cholesterol a better marker of the risk of vascular disease than low-density lipoprotein cholesterol? J Clin Lipidol.
The calculated change in low-density lipoprotein cholesterol from baseline to 24 weeks was -60.1% with alirocumab vs.
Serum LDL-C and very low-density lipoprotein cholesterol (VLDL-C) were calculated as per the Friedewald equation.
Nonfasting total cholesterol (TC), high-density lipoprotein cholesterol (HDL), and low-density lipoprotein cholesterol (LDL) levels are equally predictive of cardiovascular mortality and all-cause mortality.
A comparison of methods for the estimation of plasma low- and very low-density lipoprotein cholesterol: the Lipid Research Clinics Prevalence Study.
STATINS work by reducing the amount of low-density lipoprotein cholesterol - also known as "bad cholesterol" - that can lead to cardiovascular disease.
Both low-density lipoprotein cholesterol (LDL-C) and ApoB/ApoA-I ratio were independent risk factors for Mets, and ApoB/ApoA-I ratio was stronger in this regard for obese population [18].
Calculated values of low-density lipoprotein cholesterol in the assessment of lipid abnormalities and coronary disease risk.
An analysis of patients with coronary heart disease (CHD) who attained low-density lipoprotein cholesterol (LDL-C) goals with no treatment intensification suggests that about one-third of them underwent repeat testing anyway.
Full browser ?